Prospective Study of Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer
Latest Information Update: 24 Apr 2024
At a glance
- Drugs Sorafenib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 18 Apr 2024 Status changed from recruiting to completed.
- 27 Jun 2018 New trial record